Researchers identified mutations in a gene that are associated with greater muscle mass and lower abdominal fat. The effects appear to offer broad health benefits, potentially informing new treatments for obesity and metabolic disorders. These findings highlight a genetic pathway that could be targeted for future therapies.

Researchers developed a membranolytic peptide that ruptures tumor cell membranes, inducing immunogenic cell death. This process releases danger signals that activate the immune system against cancer, potentially enhancing existing immunotherapy approaches.

New research explores whether the quantum vacuum—the seemingly empty space between particles—can interact with light and modify its behavior. The findings probe fundamental physics and could deepen understanding of light-matter interactions, with potential implications for quantum optics and future technologies.

Researchers have created detailed maps of chromosomal regions essential for cell division, revealing unexpectedly high diversity across different organisms. This finding challenges assumptions about how these fundamental genomic elements are conserved, with implications for understanding evolution and chromosome behavior.

Scientists used a quantum simulator to observe a pseudogap, a partial gap in electronic states, in the Fermi–Hubbard model. This phenomenon is closely tied to high-temperature superconductivity and helps clarify how it emerges from strongly correlated electrons. The result provides a new experimental platform for studying quantum materials.

Researchers identified an ancient mitochondrial mechanism that adjusts protein translation in response to heme availability. This discovery reveals a previously unknown regulatory circuit in cells. It matters because it could deepen understanding of fundamental cellular physiology and diseases linked to heme or mitochondrial dysfunction.

Researchers in Nature identified a cholinergic hub in the nucleus accumbens, a key brain area, that regulates learning about opioid rewards. The finding illuminates the neural circuitry behind opioid reward processing, offering a potential target for future addiction treatments.

Researchers assembled a large biobank of organoids grown from patient tumors and used it to systematically identify genes that cancer cells rely on to survive. The resource reveals new potential drug targets and helps prioritize which cancer dependencies are most treatable.

Researchers identified a novel molecular glue degrader that relies on the protein DCAF11 and becomes active through glutathionylation, a cellular modification. This discovery expands how targeted protein degradation can be controlled, potentially paving the way for new therapeutic approaches against disease-causing proteins.